Canada Markets open in 9 hrs 29 mins

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1200-0.1032 (-8.44%)
At close: 10:58AM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 5N/A
Enterprise Value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.9300
52 Week Low 30.6200
50-Day Moving Average 31.1934
200-Day Moving Average 31.1897

Share Statistics

Avg Vol (3 month) 31.92k
Avg Vol (10 day) 34.01k
Shares Outstanding 511.39M
Implied Shares Outstanding 6N/A
Float 87.87M
% Held by Insiders 15.22%
% Held by Institutions 124.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin -13.62%
Operating Margin (ttm)20.29%

Management Effectiveness

Return on Assets (ttm)5.60%
Return on Equity (ttm)-56.50%

Income Statement

Revenue (ttm)68.09M
Revenue Per Share (ttm)5.98
Quarterly Revenue Growth (yoy)27.40%
Gross Profit (ttm)51.48M
Net Income Avi to Common (ttm)-9.28M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.27M
Total Cash Per Share (mrq)2.39
Total Debt (mrq)98.77M
Total Debt/Equity (mrq)819.97
Current Ratio (mrq)2.05
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)25.18M
Levered Free Cash Flow (ttm)16.39M